Related Experiment Video
Updated: May 5, 2026

Isolation of Soluble and Insoluble PrP Oligomers in the Normal Human Brain
Published on: October 3, 2012
Unusual cerebral vascular prion protein amyloid distribution in scrapie-infected transgenic mice expressing
Alejandra Rangel1, Brent Race, Mikael Klingeborn
1Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, Hamilton, MT 59840, USA. bchesebro@nih.gov.
Background:
In some prion diseases, misfolded aggregated protease-resistant prion protein (PrPres) is found in brain as amyloid, which can cause cerebral amyloid angiopathy. Small diffusible precursors of PrPres amyloid might flow with brain interstitial fluid (ISF), possibly accounting for the perivascular and intravascular distribution of PrPres amyloid. We previously reported that PrPres amyloid in scrapie-infected transgenic mice appeared to delay clearance of microinjected brain ISF tracer molecules.
Results:
Here we studied distribution of PrPres amyloid on capillaries, arteries and veins to test whether vascular specificity of PrPres corresponded to distribution of ISF tracer molecules. To distinguish PrPres-positive arteries from veins and capillaries, scrapie-infected mouse brains were studied by immunodetection of alpha smooth muscle actin. ISF was studied using fluorescein-labeled ovalbumin microinjected into brain as a tracer. In infected preclinical or clinical mice, PrPres was found mostly on capillaries (73-78%). Lower levels were found on arteries (11-14%) and veins (11-13%). Compared to PrPres, ISF tracer was found at higher levels on capillaries (96-97%), and the remaining tracer was found at a skewed ratio of 4 to 1 on arteries and veins respectively.
Conclusions:
PrPres association with blood vessels suggested that ISF flow might transport diffusible PrPres precursor molecules to perivascular sites. However, the different vascular specificity of PrPres and ISF tracer indicated that ISF flow did not alone control PrPres dissemination. Possibly blood vessel basement membrane (BM) components, such as glucosaminoglycans, might concentrate small PrPres aggregates and serve as scaffolds for PrP conversion on multiple vessel types.
Insights
Prion protein (PrPres) amyloid deposits in the brain primarily associate with capillaries, not solely following interstitial fluid (ISF) flow. This suggests blood vessel components, not just ISF, may influence prion spread in the brain.
Area of Science:
- Neuroscience
- Prion Disease Research
- Vascular Biology
Background:
- Prion diseases involve misfolded prion protein (PrPres) forming amyloid, potentially causing cerebral amyloid angiopathy.
- Small PrPres precursors may travel via brain interstitial fluid (ISF), explaining perivascular and intravascular PrPres amyloid distribution.
- Previous studies indicated PrPres amyloid delays ISF tracer clearance in mice.
Purpose of the Study:
- To investigate the distribution of PrPres amyloid on brain capillaries, arteries, and veins.
- To determine if PrPres vascular distribution correlates with ISF tracer molecule distribution.
- To elucidate the mechanisms of PrPres dissemination in prion diseases.
Main Methods:
- Scrapie-infected mouse brains were analyzed using immunodetection for PrPres and alpha smooth muscle actin to differentiate vessel types.
- Fluorescein-labeled ovalbumin was microinjected into the brain as an ISF tracer.
- Quantification of PrPres and tracer distribution across capillaries, arteries, and veins.
Main Results:
- PrPres amyloid was predominantly found on capillaries (73-78%) in infected mice.
- Lower levels of PrPres were observed on arteries (11-14%) and veins (11-13%).
- ISF tracer showed higher capillary association (96-97%) with a skewed distribution favoring arteries over veins.
Conclusions:
- PrPres association with blood vessels suggests ISF flow transports precursors, but distribution differs from ISF tracers.
- ISF flow alone does not solely dictate PrPres dissemination patterns.
- Blood vessel basement membrane components may concentrate PrPres aggregates, aiding conversion and spread across vessel types.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Subviral Agents

